Autologous Cell Therapy Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00 – $ 8,900.00

Autologous Cell Therapy Market: By Source (Bone Marrow, Epidermis, and Others), By Application (Cancer, Neurodegenerative Diseases, Wound Healing, Orthopedic, CVD, Autoimmune Diseases, and Others), By End User (Hospitals, Ambulatory Centers, and Research Centers), and Geography

Request Sample

Request Methodology

Request Sample

$ PRICE - $ 3,000.00 – $ 8,900.00

Clear selection

SKU: N/A Categories: Healthcare, Pharmaceuticals

Description
Table Of Content
Company Profile

Report

Description

Autologous Cell Therapy Market size was valued at USD 5.2 billion in 2021. It is expected to reach USD 17.7 billion by 2028, growing at a CAGR of 19.2% during 2022-28. Owing to the increase in the prevalence of various incurable diseases and it is an effective and safer technology when compared to that of the existing transplantation technologies in the market. Moreover, benefits such as reduction of risks which are associated with bio-incompatibility, disease transmission and immunological reactions drives the growth of the market. The therapy involves treating a patient’s own cells or tissues outside the body before reintroducing them into the donor. Currently, aesthetic and cosmetic dermatology, modern medicine, and orthopaedics all employ this kind of therapy. A number of autologous therapies exist with the goals of promoting wound healing, reducing chronic inflammation, and promoting wound closure. Autologous cell treatment draws on a variety of scientific disciplines and technologies, from virology to cellular and molecular biology. The Autologous blood vessel and artery grafts have also been used for a very long time in heart disease.

Autologous Cell Therapy Market

MARKET SUMMARY

19.2%

Study Period– 2022 – 2028
Base Year– 2021
CAGR– 19.2%
Largest Market– Asia-Pacific
Fastest Growing Market– North-America

Autologous Cell Therapy Market

The global autologous cell therapy market report gives comprehensive outlook on autologous cell therapy across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
The report on global autologous cell therapy market gives historical, current, and future market sizes (US$ Mn) on the basis of source, application, end user, and region.
Key stakeholders of the global autologous cell therapy market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global autologous cell therapy products.

Key Players

Vericel Corporation
Holostem Advanced Therapies
Osiris Therapeutics
Opexa Therapeutics
BioTime Inc.
Phamicell Co. Inc.

Autologous Cell Therapy Market Dynamics

Sedentary lifestyle and poor dietary choices has fuelled the growth of the malignancy across the world. As per American Cancer Society, a million people are suffering from cancer in United States alone. Moreover, rising funds form the government and private organizations support in cell therapy clinical trials and proven effectiveness of products coupled declining prices of stem cell therapies drives the growth of the market.

North-America Got Significant Share

Autologous Cell Therapy Market

North America accounted for larger revenue share in global autologous cell therapy market with significant CAGR owing to increased investments for treatment facilities and presence of large number of companies and strong regulatory framework to promote cell therapies and high cost for the therapy in United States drives the growth of the market. Asia Pacific region is expected to be the fastest growing region over the forecast period owing to rising medical tourism to the region and improvements in healthcare infrastructure in countries like India and China.

Latin-America

North-America

Europe

Asia-Pacific

Middle East

Key

Features of the Report

The report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup’s details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Autologous Cell Therapy Market Segmentation

By Source

Bone Marrow
Epidermis
Others

By Application

Cancer
Neurodegenerative Diseases
Wound Healing
orthopedic
CVD
Autoimmune
Others

By End User

Hospitals
Ambulatory Centers
Research Centers

Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Report

Table Of Content

1. Executive Summary

2. Global Autologous Cell Therapy Market Introduction

2.1. Global Autologous Cell Therapy Market – Taxonomy

2.2. Global Autologous Cell Therapy Market –Definitions

2.2.1. Source

2.2.2. Application

2.2.3. End User

2.2.4. Region

3. Global Autologous Cell Therapy Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Current Trends

3.5. Global Autologous Cell Therapy Market Dynamic Factors – Impact Analysis

3.6. Mergers, Acquisitions, and Collaborations

4. Global Autologous Cell Therapy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028

4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Autologous Cell Therapy Market, By Source, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.1. Bone Marrow

5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Epidermis

5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Mesenchymal Stem Cells

5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

5.4. Hematopoietic Stem Cells

5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.4.3. Market Opportunity Analysis

5.5. Chondrocytes

5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.5.3. Market Opportunity Analysis

6. Global Autologous Cell Therapy Market, By Application, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.1. Cancer

6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Neurodegenerative Diseases

6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Wound Healing

6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Orthopedic

6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

6.5. Cardiovascular Diseases

6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.5.3. Market Opportunity Analysis

6.6. Autoimmune Diseases

6.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.6.3. Market Opportunity Analysis

6.7. Others

6.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.7.3. Market Opportunity Analysis

7. Global Autologous Cell Therapy Market, By End User, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.1. Hospitals and Clinics

7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Academic and Research Institutes

7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Others

7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

8. Global Autologous Cell Therapy Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.1. North America

8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Europe

8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Asia Pacific

8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Latin America

8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. MEA

8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

8.6. Global Autologous Cell Therapy Market – Opportunity Analysis Index, By Source, Application, End User, and Country, 2022 – 2028

9. North America Autologous Cell Therapy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.1. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.1.1. Bone Marrow

9.1.2. Epidermis

9.1.3. Mesenchymal Stem Cells

9.1.4. Hematopoietic Stem Cells

9.1.5. Chondrocytes

9.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.2.1. Cancer

9.2.2. Neurodegenerative Diseases

9.2.3. Wound Healing

9.2.4. Orthopedic

9.2.5. Cardiovascular Diseases

9.2.6. Autoimmune Diseases

9.2.7. Others

9.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.3.1. Hospitals and Clinics

9.3.2. Academic and Research Institutes

9.3.3. Others

9.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.4.1. United States

9.4.2. Canada

9.5. North America Autologous Cell Therapy Market – Opportunity Analysis Index, By Source, Application, End User, 2016-2027

9.6. North America Autologous Cell Therapy Market Dynamics – Trends

10. Europe Autologous Cell Therapy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

10.1. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Bone Marrow

10.1.2. Epidermis

10.1.3. Mesenchymal Stem Cells

10.1.4. Hematopoietic Stem Cells

10.1.5. Chondrocytes

10.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.2.1. Cancer

10.2.2. Neurodegenerative Diseases

10.2.3. Wound Healing

10.2.4. Orthopedic

10.2.5. Cardiovascular Diseases

10.2.6. Autoimmune Diseases

10.2.7. Others

10.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.3.1. Hospitals and Clinics

10.3.2. Academic and Research Institutes

10.3.3. Others

10.4. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.4.1. UK

10.4.2. Germany

10.4.3. France

10.4.4. Italy

10.4.5. Spain

10.4.6. Rest of Europe

10.5. Europe Autologous Cell Therapy Market – Opportunity Analysis Index, By Source, Application, End User, 2016-2027

10.6. Europe Autologous Cell Therapy Market Dynamics – Trends

11. Asia Pacific Autologous Cell Therapy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

11.1. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Bone Marrow

11.1.2. Epidermis

11.1.3. Mesenchymal Stem Cells

11.1.4. Hematopoietic Stem Cells

11.1.5. Chondrocytes

11.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.2.1. Cancer

11.2.2. Neurodegenerative Diseases

11.2.3. Wound Healing

11.2.4. Orthopedic

11.2.5. Cardiovascular Diseases

11.2.6. Autoimmune Diseases

11.2.7. Others

11.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.3.1. Hospitals and Clinics

11.3.2. Academic and Research Institutes

11.3.3. Others

11.4. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.4.1. China

11.4.2. India

11.4.3. ANZ

11.4.4. Japan

11.4.5. Rest of APAC

11.5. Asia Pacific Autologous Cell Therapy Market – Opportunity Analysis Index, By Source, Application, End User, 2016-2027

11.6. Asia Pacific Autologous Cell Therapy Market Dynamics – Trends

12. MEA Autologous Cell Therapy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

12.1. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Bone Marrow

12.1.2. Epidermis

12.1.3. Mesenchymal Stem Cells

12.1.4. Hematopoietic Stem Cells

12.1.5. Chondrocytes

12.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.2.1. Cancer

12.2.2. Neurodegenerative Diseases

12.2.3. Wound Healing

12.2.4. Orthopedic

12.2.5. Cardiovascular Diseases

12.2.6. Autoimmune Diseases

12.2.7. Others

12.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.3.1. Hospitals and Clinics

12.3.2. Academic and Research Institutes

12.3.3. Others

12.4. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.4.1. GCC Countries

12.4.2. South Africa

12.4.3. Rest of MEA

12.5. MEA Autologous Cell Therapy Market – Opportunity Analysis Index, By Source, Application, End User, 2016-2027

12.6. MEA Autologous Cell Therapy Market Dynamics – Trends

13. Latin America Autologous Cell Therapy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

13.1. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.1.1. Bone Marrow

13.1.2. Epidermis

13.1.3. Mesenchymal Stem Cells

13.1.4. Hematopoietic Stem Cells

13.1.5. Chondrocytes

13.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.2.1. Cancer

13.2.2. Neurodegenerative Diseases

13.2.3. Wound Healing

13.2.4. Orthopedic

13.2.5. Cardiovascular Diseases

13.2.6. Autoimmune Diseases

13.2.7. Others

13.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.3.1. Hospitals and Clinics

13.3.2. Academic and Research Institutes

13.3.3. Others

13.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.4.1. Brazil

13.4.2. Mexico

13.4.3. Argentina

13.4.4. Rest of LA

13.5. Latin America Autologous Cell Therapy Market – Opportunity Analysis Index, By Source, Application, End User, 2016-2027

13.6. Latin America Autologous Cell Therapy Market Dynamics – Trends

14. Competition Landscape

14.1. Strategic Dashboard of Top Market Players

14.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis)

14.2.1. Brainstorm Cell Therapeutics

14.2.2. Vericel Corporation

14.2.3. Holostem Advanced Therapies

14.2.4. Osiris Therapeutics

14.2.5. Opexa Therapeutics

14.2.6. BioTime Inc.

14.2.7. Phamicell Co. Inc.

14.2.8. Sangamo Therapeutics

14.2.9. Calimmune, Inc.

14.2.10. Bayer, Inc.

15. Research Methodology

16. Key Assumptions and Acronyms

Description

search

Autologous Cell Therapy Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

Description

Autologous Cell Therapy Market

Autologous Cell Therapy Market

Features of the Report

By Source

By Application

By End User

GEOGRAPHY

Frequently Asked Questions

Table Of Content

Company Profile

Description

Product categories

Our Clients

ASIA PACIFIC OFFICE

EUROPE OFFICE